Network Medicine‐Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD‐L1 Expression via Targeting SPOP in Cancer

Documenti analoghi

• Cordycepin Targets HRD1 to Promote Cancer Cell PD‐L1 Ubiquitin–Proteasome Degradation and Increase Antitumor Immunity
  di: Xiangxin Geng, et al.
  Pubblicazione: (2025)
• Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation
  di: Hongmei Hu, et al.
  Pubblicazione: (2024)
• Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation (Adv. Sci. 7/2025)
  di: Hongmei Hu, et al.
  Pubblicazione: (2025)
• 5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1
  di: Jianhua Xia, et al.
  Pubblicazione: (2024)
• Marine Natural Product Chagosendine C Induces Cuproptosis in Colorectal Cancer Cells by Targeting FDX1.
  di: Tao, Xiaoyu, et al.
  Pubblicazione: (2025)